I would love a 3 figure BO as would any of us, I think, but
I would love a 3 figure BO as would any of us, I think, but I just don't see how it is so realistic, given that anyone buying CYDY would have to do all of the heavy lifting. Leronlimab may be the best drug in the world, but thus far, we have had zero success and/or luck in getting the world to acknowledge what it can do, for various reasons.
A partner or purchaser would probably factor in how much work they would have to do and money they would have to spend on additional trials, etc.
I have no idea whatsoever to value CYDY at but 3 figures seems very pie in the sky to me as of today for a stock sitting at $.50
If there was a BO, I would prefer cash and stock or maybe some kind of cash plus stock plus milestone cash along the way. I am not saying that $10 is acceptable, but I still remind you that 100% of $0 is $0.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Yoshiharu Global Stock Faces Major Challenges Yoshiharu Global Co. is currently navigating through turbulent waters, as evidenced by the stock reaching a concerning 52-week low of $2.7. This decline starkly contrasts its previous performance, revealing a significant drop of 43.1% in value over the past year. Investors are reflecting on the broader market conditions and...
Continue Reading
Class Action Lawsuit Filed Against Nextracker Inc. Investors are being informed about a recent class action lawsuit that has been initiated concerning Nextracker Inc. (NASDAQ: NXT). This case was filed on behalf of all individuals and entities who acquired shares of Nextracker’s common stock during a specified period. Nextracker, known for its innovative solar...
Continue Reading
Boba Mint Holdings Celebrates Impressive Milestones in Gaming Boba Mint Holdings Ltd. (CSE: TNJ) recently announced outstanding milestones in user growth for its flagship blockchain mobile game, Tanjea. Following the last update on user downloads back in May, the company has reported that total downloads for Tanjea have now exceeded 409,670, with an impressive count of...
Continue Reading
Tixel i® Revolutionizes Dry Eye Treatment A recent publication highlights the remarkable advancements Tixel i® has brought to the field of ophthalmology, particularly for patients dealing with Evaporative Dry Eye Disease (DED) linked to Meibomian Gland Dysfunction (MGD). This cutting-edge technology has gained recognition for its effectiveness in providing long-lasting...
Continue Reading
ClarityPay Enhances Leadership with MJ Panda as COO ClarityPay, a frontrunner in customized point-of-sale credit solutions, has appointed Mrutyunjaya "MJ" Panda as its new Chief Operating Officer. Panda brings with him an impressive background, having held significant roles at both Goldman Sachs and American Express, where he developed a wealth of knowledge in risk...
Continue Reading
